Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Cross-Sectional Study

Management of Postmenopausal Osteoporosis by Moroccan General Practitioners: A Cross-Sectional Survey

Author(s): Ahmed Mougui* and Imane El Bouchti

Volume 20, Issue 1, 2024

Published on: 15 August, 2023

Page: [100 - 106] Pages: 7

DOI: 10.2174/1573397119666230731122645

Price: $65

Abstract

Background: Despite the existence of effective treatments and prescribed therapeutic protocols, there is a lack of management of osteoporosis, resulting in increased secondary morbidity and mortality. The general practitioner (GP) is the first-line practitioner for the detection and management of osteoporosis.

Objective: This study was conducted to explore the practices, knowledge, and difficulties in postmenopausal osteoporosis management reported by GPs.

Methods: An anonymous questionnaire (19 questions) was created via Google Forms and distributed to 300 GPs via social networks (WhatsApp, Facebook, and Gmail). The survey results were automatically calculated on “Google Forms” and checked using SPSS.20 software.

Results: A total of 129 responses were received, representing a response rate of 43%. The majority of respondents were women (67.2%). The definition of osteoporosis was variable, with 51.6% defining it as a T-score of ≤-2.5 SD, 25.8% defining it as diffuse bone demineralization, and 12.1% defining it as a fracture after falling with low energy. Prolonged corticosteroid therapy was the most commonly indicated reason for measuring bone mineral density (BMD) (81.39%). The calcium phosphate balance was the most requested (90.1%). Vitamin D and calcium supplementation were reported by 74.41% and 54.26% of GPs, respectively. Fracture of the upper end of the femur was the main therapeutic indication (65.11%). Most GPs surveyed (73.3%) were unfamiliar with the fracture risk assessment tool (FRAX). Most of the GPs gave advice on fall prevention to their patients (83.72%), and 62.5% of GPs monitored their patients' height. Anti-osteoporosis treatment was maintained for 3 to 5 years by 44.96% of GPs.

Conclusion: Our survey found that the practices and knowledge of GPs on osteoporosis vary widely and often deviate from the recommended standards. This highlights the need for more excellent education of GPs, due to their vital role in the management of osteoporosis.

« Previous Next »
Graphical Abstract

[1]
Consensus development conference. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94(6): 646-50.
[http://dx.doi.org/10.1016/0002-9343(93)90218-E] [PMID: 8506892]
[2]
Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019; 30(1): 3-44.
[http://dx.doi.org/10.1007/s00198-018-4704-5] [PMID: 30324412]
[3]
Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clin Med (Lond) 2014; 14(2): 187-91.
[http://dx.doi.org/10.7861/clinmedicine.14-2-187] [PMID: 24715132]
[4]
Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phe-nomenon. Semin Arthritis Rheum 2006; 35(5): 293-305.
[http://dx.doi.org/10.1016/j.semarthrit.2005.11.001] [PMID: 16616152]
[5]
Siris ES, Gehlbach S, Adachi JD, et al. Failure to perceive increased risk of fracture in women 55 years and older: The Global Longitudi-nal Study of Osteoporosis in Women (GLOW). Osteoporos Int 2011; 22(1): 27-35.
[http://dx.doi.org/10.1007/s00198-010-1211-8] [PMID: 20358360]
[6]
Merle B, Haesebaert J, Bedouet A, et al. Osteoporosis prevention: Where are the barriers to improvement in French general practitioners? A qualitative study. PLoS One 2019; 14(7): e0219681.
[http://dx.doi.org/10.1371/journal.pone.0219681] [PMID: 31310619]
[7]
Wiboe L, Jacobsen IB, Mogensen CB. Osteoporosis prevention in general practice after hospitalization for hip fracture. Ugeskr Laeger 2002; 164(20): 2610-3.
[PMID: 12043403]
[8]
Naik-Panvelkar P, Norman S, Elgebaly Z, et al. Osteoporosis management in Australian general practice: An analysis of current osteopo-rosis treatment patterns and gaps in practice. BMC Fam Pract 2020; 21(1): 32.
[http://dx.doi.org/10.1186/s12875-020-01103-2] [PMID: 32050909]
[9]
Otmar R, Reventlow SD, Nicholson GC, Kotowicz MA, Pasco JA. General medical practitioners’ knowledge and beliefs about osteoporosis and its investigation and management. Arch Osteoporos 2012; 7(1-2): 107-14.
[http://dx.doi.org/10.1007/s11657-012-0088-x] [PMID: 23225288]
[10]
Kanis J. Assessment of osteoporosis at the primary health-care level Technical Report. 2008. Available from: http://www.shef.ac
[11]
Kline GA, Symonds CJ, Billington EO. A retrospective review of the community medicine needs from osteoporosis services in Canada. BMC Endocr Disord 2022; 22(1): 78.
[http://dx.doi.org/10.1186/s12902-022-01000-y] [PMID: 35346169]
[12]
Dorner T, Lawrence K, Rebhandl E, Weichselbaum E, Rieder A. Opinions and attitudes concerning osteoporosis among Austrian general practitioners. Wien Med Wochenschr 2009; 159(9-10): 247-52.
[http://dx.doi.org/10.1007/s10354-009-0648-x] [PMID: 19484208]
[13]
Schnatz PF, Marakovits KA, DuBois M, O’Sullivan DM. Osteoporosis screening and treatment guidelines. Menopause 2011; 18(10): 1072-8.
[http://dx.doi.org/10.1097/gme.0b013e318215101a] [PMID: 21753740]
[14]
Frayssinet C, Trémollieres F. Postmenopausal osteoporosis: when is it necessary to perform laboratory testing? Which testing strategy?. Gynécol Obstét Fertil 2008; 36(6): 656-8.
[http://dx.doi.org/10.1016/j.gyobfe.2008.04.005] [PMID: 18539507]
[15]
Briot K, Roux C, Thomas T, et al. 2018 update of French recommendations on the management of postmenopausal osteoporosis. Joint Bone Spine 2018; 85(5): 519-30.
[http://dx.doi.org/10.1016/j.jbspin.2018.02.009] [PMID: 29654947]
[16]
Guideline for the prevention of falls in older persons. American geriatrics society, british geriatrics society, and american academy of orthopaedic surgeons panel on falls prevention. J Am Geriatr Soc 2001; 49(5): 664-72.
[PMID: 11380764]
[17]
FERREIRA Jr LH Jr, MENDONÇA Jr KD Jr, CHAVES de SOUZA J, et al. Bisphosphonate-associated osteonecrosis of the jaw. Minerva Dent Oral Sc 2021; 70(1): 49-57.
[http://dx.doi.org/10.23736/S2724-6329.20.04306-X] [PMID: 32960522]
[18]
Jaglal SB, Carroll J, Hawker G, et al. How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician 2003; 49: 462-8.
[PMID: 12729242]
[19]
Levinson MR, Clay FJ. Barriers to the implementation of evidence in osteoporosis treatment in hip fracture. Intern Med J 2009; 39(3): 199-202.
[http://dx.doi.org/10.1111/j.1445-5994.2008.01872.x] [PMID: 19383069]
[20]
Giammattei F, Giammattei J, Howland V. Physician follow-up care for osteoporosis after fragility fractures. Phys Sportsmed 2009; 37(4): 62-7.
[http://dx.doi.org/10.3810/psm.2009.12.1743] [PMID: 20048542]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy